Ira Smalberg, MD
Diagnostic Radiology · Santa Monica, CANPI 1952356255
Payments from drug & device makers
Across 483 payments — averaging $1977.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$301K
- Merck$238K
- Acerta Pharma LLC$169K
- Pharmacyclics LLC, An Abbvie Company$69K
- Janssen Research & Development, LLC$57K
- Novartis$32K
- plus $89K from 14 others
Across 87 payments — averaging $17,698 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$1.5M
- Eli Lilly$23K
- Morphosys AG$5K
- AbbVie$5K
- Pharmacyclics LLC, An Abbvie Company$2K
- Beigene, Ltd.$2K
- plus $2K from 3 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 32 | $300,686 |
| Merck | 304 | $238,121 |
| Acerta Pharma LLC | 6 | $169,445 |
| Pharmacyclics LLC, An Abbvie Company | 24 | $69,128 |
| Janssen Research & Development, LLC | 23 | $56,625 |
| Novartis | 7 | $32,460 |
| Amgen | 2 | $24,560 |
| Boehringer Ingelheim International GmbH | 24 | $22,168 |
| Beigene, Ltd. | 25 | $19,580 |
| AbbVie | 9 | $6,730 |
| Seagen Inc. | 4 | $5,380 |
| Morphosys AG | 6 | $3,175 |
| Eli Lilly | 1 | $1,600 |
| Pfizer | 1 | $1,590 |
| Medivation LLC. | 2 | $1,350 |
| Incyte Corporation | 4 | $900 |
| Beone Medicines Ltd. | 3 | $810 |
| Astrazeneca AB | 1 | $690 |
| Novo Nordisk | 3 | $53 |
| Siemens Medical Solutions USA, Inc. | 2 | $41 |
How this compares
$955,091 in reported general payments places this provider in the 95th percentile of 3,537 diagnostic radiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic radiology in Santa Monica
- Christopher LohSanta Monica$138K
- Michael WangEscondido$14M
- Murray ReicherSan Diego$10.5M
- Charles PeterfyKentfield$8.1M
- Garry GoldStanford$6M
- Gary UlanerLos Angeles$3.3M
- Jerome BarakosSan Francisco$2.5M
- Armonde BaghdanianLos Angeles$2.1M
- Curtis LanglotzStanford$1.8M
- Albert HsiaoSan Diego$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.